These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10357665)

  • 1. Startling revelations in UC-Genentech battle.
    Marshall E
    Science; 1999 May; 284(5416):883, 885-6. PubMed ID: 10357665
    [No Abstract]   [Full Text] [Related]  

  • 2. Biotech patents. Genentech, UC settle suit for $200 million.
    Barinaga M
    Science; 1999 Nov; 286(5445):1655. PubMed ID: 10610555
    [No Abstract]   [Full Text] [Related]  

  • 3. UC-Genentech trial.
    Seeburg PH
    Science; 1999 May; 284(5419):1465-6. PubMed ID: 10383323
    [No Abstract]   [Full Text] [Related]  

  • 4. Genentech pays $200m over growth hormone 'theft'.
    Dalton R; Schiermeier Q
    Nature; 1999 Nov; 402(6760):335. PubMed ID: 10586857
    [No Abstract]   [Full Text] [Related]  

  • 5. No winners in patent shootout.
    Barinaga M
    Science; 1999 Jun; 284(5421):1752-3. PubMed ID: 10391787
    [No Abstract]   [Full Text] [Related]  

  • 6. UC-Genentech trial.
    Henner D; Goeddel DV; Heyneker H; Itakura K; Tansura D
    Science; 1999 May; 284(5419):1465. PubMed ID: 10383322
    [No Abstract]   [Full Text] [Related]  

  • 7. Charges fly in $1bn hormone patent battle.
    Dalton R
    Nature; 1999 May; 399(6734):289. PubMed ID: 10360558
    [No Abstract]   [Full Text] [Related]  

  • 8. US jury split over hormone patent case..
    Dalton R
    Nature; 1999 Jun; 399(6736):512. PubMed ID: 10376586
    [No Abstract]   [Full Text] [Related]  

  • 9. Ownership at too high a price?
    Nat Biotechnol; 2003 Sep; 21(9):953. PubMed ID: 12949537
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotechs sue Columbia over fourth Axel patent.
    Howard K
    Nat Biotechnol; 2003 Sep; 21(9):955-6. PubMed ID: 12949538
    [No Abstract]   [Full Text] [Related]  

  • 11. Statement from Peter Seeburg.
    Seeburg PH
    Nature; 1999 May; 399(6734):298. PubMed ID: 10360565
    [No Abstract]   [Full Text] [Related]  

  • 12. Affymetrix in new patents row.
    Ledford H
    Nature; 2008 Jul; 454(7203):377. PubMed ID: 18650873
    [No Abstract]   [Full Text] [Related]  

  • 13. as Seeburg faces misconduct inquiry.
    Abbott A
    Nature; 1999 Jun; 399(6736):512. PubMed ID: 10376587
    [No Abstract]   [Full Text] [Related]  

  • 14. Affymetrix license valid, rules court.
    Robertson D
    Nat Biotechnol; 2001 Jan; 19(1):13-4. PubMed ID: 11135539
    [No Abstract]   [Full Text] [Related]  

  • 15. Patents. Signature on visitor's form fuels Stanford v. Roche court battle.
    Marshall E
    Science; 2011 Apr; 332(6026):163. PubMed ID: 21474725
    [No Abstract]   [Full Text] [Related]  

  • 16. EU ends 10-year battle over biopatents.
    Gavaghan H
    Science; 1998 May; 280(5367):1188. PubMed ID: 9634397
    [No Abstract]   [Full Text] [Related]  

  • 17. Biotechnology patents under fire.
    Royzman I
    Nat Biotechnol; 2015 Sep; 33(9):925-6. PubMed ID: 26348959
    [No Abstract]   [Full Text] [Related]  

  • 18. Patenting pluripotence: the next battle for stem cell intellectual property.
    Vrtovec KT; Scott CT
    Nat Biotechnol; 2008 Apr; 26(4):393-5. PubMed ID: 18392018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patents, biotechnology, and hematologic pathology.
    Kettelberger DM; Gambrell P; McClung G
    Hematol Pathol; 1992; 6(2):99-104. PubMed ID: 1607346
    [No Abstract]   [Full Text] [Related]  

  • 20. Intellectual property. NIH roils academe with advice on licensing DNA patents.
    Malakoff D
    Science; 2004 Mar; 303(5665):1757-8. PubMed ID: 15031474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.